JP Morgan Chase’s Sensus Healthcare SRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,898
Closed -$27K 7707
2024
Q4
$27K Buy
+3,898
New +$28.6K ﹤0.01% 6177
2020
Q4
Sell
-8
Closed 5913
2020
Q3
$0 Hold
8
﹤0.01% 5752
2020
Q2
$0 Buy
+8
New +$21 ﹤0.01% 5683
2019
Q2
Sell
-42
Closed 5999
2019
Q1
$0 Buy
+42
New +$324 ﹤0.01% 6027

Other funds holding SRTS

JP Morgan Chase's SRTS Position: Q1 2025 in Review

JP Morgan Chase sold out of Sensus Healthcare (SRTS) in Q1 2025, closing a stake of 3,898 shares — an estimated $27K sold.

JP Morgan Chase first reported a position in SRTS in Q1 2019 and held it in 4 quarters. The position peaked at $27K in Q4 2024. 53 funds tracked by Wall St. Rank hold SRTS as of Q1 2025.

  • JP Morgan Chase reported no remaining Sensus Healthcare position as of Q1 2025 after selling out during the quarter.
  • JP Morgan Chase sold 3,898 Sensus Healthcare shares in Q1 2025, an estimated $27K.
  • JP Morgan Chase first reported a position in Sensus Healthcare in Q1 2019 and held it in 4 quarters.
  • JP Morgan Chase's Sensus Healthcare position peaked at $27K in Q4 2024.
  • 53 funds tracked by Wall St. Rank held Sensus Healthcare as of Q1 2025.

Based on JP Morgan Chase's 13F filing for Q1 2025, filed 12 May 2025.